Bioventus Inc. (BVS), a medical device company, will report its financial results for the fourth quarter and full year 2024 before the market opens on March 11, 2025.
The company expects net sales for the full year 2024 to be in the range of $562 million to $567 million. Net sales were $512.3 million in 2023.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.